169 related articles for article (PubMed ID: 36275455)
1. A retrospective study of prevalence and pattern of international consensus on ANA patterns among patients with hepatitis C virus infection.
Hsiao SW; Fan CS; Yen HH; Huang SP; Chen YY; Su PY
PeerJ; 2022; 10():e14200. PubMed ID: 36275455
[TBL] [Abstract][Full Text] [Related]
2. Expression and clinical significance of antinuclear antibody in hepatitis C virus infection.
Peng YC; Hsieh SC; Yang DY; Tung CF; Hu WH; Huang WN; Chen GH
J Clin Gastroenterol; 2001; 33(5):402-6. PubMed ID: 11606858
[TBL] [Abstract][Full Text] [Related]
3. Antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in patients with chronic hepatitis C.
Hsieh MY; Dai CY; Lee LP; Huang JF; Tsai WC; Hou NJ; Lin ZY; Chen SC; Wang LY; Chang WY; Chuang WL; Yu ML
J Clin Pathol; 2008 Mar; 61(3):333-7. PubMed ID: 17545561
[TBL] [Abstract][Full Text] [Related]
4. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
Wu CH; Xu XY; Tian GS; Yu YY
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
6. Investigation and analysis of HEp 2 indirect immunofluorescence titers and patterns in various liver diseases.
Wei Q; Jiang Y; Xie J; Yang M; Zhang Y; Wu Z; Chen S; Liao Z; Lin Z; Gu J
Clin Rheumatol; 2020 Aug; 39(8):2425-2432. PubMed ID: 32103375
[TBL] [Abstract][Full Text] [Related]
7. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile.
Cassani F; Cataleta M; Valentini P; Muratori P; Giostra F; Francesconi R; Muratori L; Lenzi M; Bianchi G; Zauli D; Bianchi FB
Hepatology; 1997 Sep; 26(3):561-6. PubMed ID: 9303483
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of antinuclear antibodies in patients with chronic hepatitis C virus infection.
de Castro GLC; da Silva Graça Amoras E; Araújo MS; da Silva Conde SRS; Bichara CDA; Queiroz MAF; Vallinoto ACR
Eur J Med Res; 2022 Sep; 27(1):180. PubMed ID: 36114565
[TBL] [Abstract][Full Text] [Related]
9. The prevalence of autoantibody and its relationship with genotypes of hepatitis C virus in patients with chronic hepatitis C virus infection.
Kirdar S; Sener AG; Cengİz M; Aydin N
APMIS; 2016 Nov; 124(11):979-984. PubMed ID: 27670736
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of serum auto-antibodies in Chinese patients with chronic hepatitis C: negative role of serum viral titre and genotype.
Luo JC; Hwang SJ; Li CP; Lu RH; Chan CY; Wu JC; Chang FY; Lee SD
J Gastroenterol Hepatol; 1998 May; 13(5):475-9. PubMed ID: 9641643
[TBL] [Abstract][Full Text] [Related]
11. Anti-ENA antibody profiles in patients with hepatitis C virus infection.
Litwin CM; Rourk AR
J Clin Lab Anal; 2018 Mar; 32(3):. PubMed ID: 28605141
[TBL] [Abstract][Full Text] [Related]
12. Clinical and serological differentiation of autoimmune and hepatitis C virus-related chronic hepatitis.
Fried MW; Draguesku JO; Shindo M; Simpson LH; Banks SM; Hoofnagle JH; Di Bisceglie AM
Dig Dis Sci; 1993 Apr; 38(4):631-6. PubMed ID: 8384981
[TBL] [Abstract][Full Text] [Related]
13. Serum autoantibodies positivity prevalence in patients with chronic HCV and impact on pegylated interferon and ribavirin treatment response.
Khairy M; El-Raziky M; El-Akel W; Abdelbary MS; Khatab H; El-Kholy B; Esmat G; Mabrouk M
Liver Int; 2013 Nov; 33(10):1504-9. PubMed ID: 23763380
[TBL] [Abstract][Full Text] [Related]
14. Antinuclear antibody titer and treatment response to peginterferon plus ribavirin for chronic hepatitis C patients.
Hsieh MY; Dai CY; Lee LP; Huang JF; Chuang WL; Hou NJ; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Yu ML
Kaohsiung J Med Sci; 2012 Feb; 28(2):86-93. PubMed ID: 22313535
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the Prevalence of Non-Organ-Specific Autoantibodies in Egyptian Patients with HCV.
Emara M; Mohsen E; Shawky RM; El-Domany RA
Immunol Invest; 2020 Aug; 49(6):676-686. PubMed ID: 31820668
[TBL] [Abstract][Full Text] [Related]
16. [Investigation of antinuclear antibodies in chronic hepatitis B patients].
Şener AG; Aydın N; Ceylan C; Kırdar S
Mikrobiyol Bul; 2018 Oct; 52(4):425-430. PubMed ID: 30522427
[TBL] [Abstract][Full Text] [Related]
17. The influence of demography and referral medical specialty on the detection of autoantibodies to HEP-2 cells in a large sample of patients.
Santos WFS; Cantuária APC; Félix DC; Nardes LK; de Melo ICS
Adv Rheumatol; 2022 Aug; 62(1):32. PubMed ID: 35971154
[TBL] [Abstract][Full Text] [Related]
18. Effect of hepatitis C virus on hemoglobin and hematocrit levels in saudi hemodialysis patients.
Alsaran KA; Sabry AA; Alghareeb AH; Al Sadoon G
Ren Fail; 2009; 31(5):349-54. PubMed ID: 19839833
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies in chronic liver disease.
Ghonaim M; Al-Ghamdi A; El-Bana H; Bakr A; Ghoneim E; El-Edel R; Hassona M; Shoeib S; Allam H
Egypt J Immunol; 2005; 12(2):101-11. PubMed ID: 17977215
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and Outcome of Serum Autoantibodies in Chronic Hepatitis C Patients Undergoing Direct-Acting Antiviral Treatment.
Romano C; Tortorella O; Dalla Mora L; Di Stasio D; Sellitto A; Adinolfi LE; Marrone A
Front Immunol; 2022; 13():882064. PubMed ID: 35479086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]